Cobimetinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. COBIMETINIB (koe bi me ti nib) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat certain types of melanoma, a skin cancer. This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.Cobimetinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Cobimetinib Nitroso Impurity 2 CAS NO:NA chemically represented as (S)-N-(2,3-Difluoro-6-(3-hydroxy-3-(1-nitrosopiperidin-2-yl)azetidine-1-carbonyl)phenyl)-N-(2-fluoro-4-iodophenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Cobimetinib Nitroso Impurity 2 . We supply Cobimetinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines."
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014467 |
| CAS No | NA |
| Mol.F. | C19H18FN5O4 |
| Mol.Wt. | 399.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014469 |
| CAS No | NA |
| Mol.F. | C28H35ClN6O4S |
| Mol.Wt. | 587.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014470 |
| CAS No | NA |
| Mol.F. | C28H34ClN7O5S |
| Mol.Wt. | 616.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014471 |
| CAS No | NA |
| Mol.F. | C28H34ClN7O5S |
| Mol.Wt. | 616.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014472 |
| CAS No | NA |
| Mol.F. | C27H27N3O8 |
| Mol.Wt. | 521.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014473 |
| CAS No | NA |
| Mol.F. | C18H25ClN4O |
| Mol.Wt. | 348.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014474 |
| CAS No | 1053740-92-3 |
| Mol.F. | C22H30N4O6 |
| Mol.Wt. | 446.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014475 |
| CAS No | NA |
| Mol.F. | C28H35ClN6O4S |
| Mol.Wt. | 587.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014476 |
| CAS No | NA |
| Mol.F. | C13H10ClN3O3 |
| Mol.Wt. | 291.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014477 |
| CAS No | NA |
| Mol.F. | C21H22Cl2N2O7 |
| Mol.Wt. | 485.31 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014478 |
| CAS No | NA |
| Mol.F. | C26H26N2O5 |
| Mol.Wt. | 446.5 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014479 |
| CAS No | NA |
| Mol.F. | C21H20F3IN4O3 |
| Mol.Wt. | 560.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014480 |
| CAS No | NA |
| Mol.F. | C21H20F3IN4O3 |
| Mol.Wt. | 560.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014482 |
| CAS No | NA |
| Mol.F. | C21H21Cl2FN6O2 |
| Mol.Wt. | 479.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014483 |
| CAS No | NA |
| Mol.F. | C40H49N9O7 |
| Mol.Wt. | 767.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014484 |
| CAS No | NA |
| Mol.F. | C40H48N10O8 |
| Mol.Wt. | 796.9 |
| INV STATUS | CUSTOM SYNTHESIS |